PROSPECTS FOR THE USE OF MODERN FLUOROQUINOLONES IN SURGICAL SKIN AND SOFT TISSUE INFECTIONS, AND BONE AND JOINT INFECTIONS

A broad antimicrobial spectrum of modern fluoroquinolones as well as favorable pharmacokinetic profile and potential for overwhelming several bacterial resistance mechanisms make this drug class essential in the treatment of polymicrobial infections at different body sites. This paper presents data on a high efficacy of moxifloxacin in surgical skin and soft tissue infections, and data supporting its use in the treatment of bone and joint infections.

skin and soft tissue infections, bone and joint infections, antibacterial therapy, moxifloxacin